scispace - formally typeset
A

Annika Scheynius

Researcher at Karolinska Institutet

Publications -  218
Citations -  16576

Annika Scheynius is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Malassezia sympodialis & Immunoglobulin E. The author has an hindex of 62, co-authored 215 publications receiving 15284 citations. Previous affiliations of Annika Scheynius include Karolinska University Hospital & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease.

TL;DR: An aberrant expression of ICAM-1 and HLA-DR was found in the liver in both patients with EHBA and patients with Byler's disease, indicating that it is not merely an unspecific event secondary to cholestasis.
Journal ArticleDOI

The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells

TL;DR: Evidence is provided that IL-18 is directly coupled to induction of self-reactive IgM and IgG antibody responses and recruitment of innate B2 B cells residing in the marginal zone of the spleen, and evidence that the B-cell activation occurs predominantly in splenic extrafollicular plasma cell foci and is regulated by natural killer T (NKT) cells that prevent formation of mature germinal centers.
Journal ArticleDOI

Identification of small RNAs in extracellular vesicles from the commensal yeast Malassezia sympodialis.

TL;DR: The levels of small RNAs were not significantly differentially expressed between the two different pH conditions indicating that they are not influenced by the elevated pH level observed on the AE skin.
Journal ArticleDOI

Adjuvant Properties of Mesoporous Silica Particles Tune the Development of Effector T Cells

TL;DR: Mesoporous silica particles can be used as delivery vehicles with tunable adjuvant properties, which may be of importance for several medical applications, such as immune therapy and vaccination.
Journal ArticleDOI

Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes.

TL;DR: In a comparison of their ability to stimulate CD8+ T cells, it was found that the IL‐4/IL‐3 MDDCs were slightly more efficient than the conventionalMDDCs at inducing interferon (IFN)‐γ release in response to viral peptides.